Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts
Sponsor: Universitas Sebelas Maret
Summary
This study aims to evaluate the effect of Vitamin D3 supplementation on inflammatory markers and immune status in patients with HIV who are receiving antiretroviral therapy. Participants will receive Vitamin D3 supplementation for 3 months. Outcomes including Interleukin-6 levels and CD4 counts will be measured to assess the potential benefits of this intervention.
Official title: The Effect of Vitamin D3 Supplementation on Interleukin-6 Levels and Cluster of Differentiation 4 Counts in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy
Key Details
Gender
All
Age Range
19 Years - 59 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-06-01
Completion Date
2025-09-30
Last Updated
2026-04-27
Healthy Volunteers
No
Conditions
Interventions
Vitamin D3
Participants receive oral Vitamin D3 supplementation at a dose of 5000 IU daily for 3 months in addition to standard antiretroviral therapy
Antiretroviral (ARV) medications
Participants receive standard antiretroviral therapy.
Locations (1)
Voluntary Counseling and Testing (VCT) Clinic, Dr. Moewardi General Hospital, Surakarta, Indonesia
Surakarta, Central Java, Indonesia